{"nct_id":"NCT01455389","title":"TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer","status":"TERMINATED","status_verified_date":"2022-02","start_date":"2014-02","start_date_type":"ACTUAL","primary_completion_date":"2016-10-27","primary_completion_date_type":"ACTUAL","completion_date":"2020-09-28","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["GNPX"]}